What is Biote?
Biote operates at the intersection of longevity science and personalized medicine, positioning itself as a transformative force in the healthcare landscape. Rather than adhering to traditional anti-aging paradigms, the company champions the concept of healthy aging, recognizing that each patient requires a unique, data-informed approach. By developing sophisticated educational programs and comprehensive patient management solutions, Biote empowers healthcare providers to proactively address the early indicators of aging. This model not only enhances clinical outcomes but also establishes a scalable framework for practitioners to deliver high-touch, personalized care in an increasingly complex medical environment.
How much funding has Biote raised?
Biote has raised a total of $175M across 1 funding round:
Debt
$175M
Debt (2021): $175M with participation from Truist Securities
Key Investors in Biote
Truist Securities
Truist Securities is a full-service corporate and investment banking firm that provides strategic financial solutions and capital market expertise to support the growth of established enterprises.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Biote?
With the recent influx of capital, Biote is well-positioned to scale its operational infrastructure and expand its reach within the medical provider community. The strategic deployment of these funds will likely focus on enhancing the company's proprietary educational platforms and refining its patient management tools to meet the growing demand for longevity-focused healthcare. As the company moves into its next phase of growth, the focus will remain on maintaining clinical excellence while broadening its footprint in the preventative medicine market. By leveraging its current financial momentum, Biote aims to set new standards for how healthcare systems approach the aging process, ensuring that providers are equipped with the most advanced resources to support patient health over the long term.
See full Biote company page
